HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
LUNR
LUNAR CORP
Healthcare Medical Devices Delisted · Wisconsin, USA · Reports in usd
Market Cap: $6.45B
Market Cap
$6.45B
Enterprise Val
$6.63B
P/E Ratio
-58.65
P/B Ratio
-19.28
Trailing PEG (1Y)
-0.46
As Of
Jun 7, 2026

Overview & Key Metrics

Reporting period: Mar 31, 2026 · Q1 2026
Book Value$731.2M
Gross Margin16.12%
Profit Margin16.12%
Return on Equity23.45%
Return on Assets-11.87%
Current Ratio1.22
Debt/Equity-1.28
LT Debt/Equity-1.19
Revenue Per Share0.86

Income Statement

Mar 31, 2026
Revenue$186.7M
Cost of Revenue$156.6M
Gross Profit$30.1M
R&D$5.6M
SG&A$50.7M
Operating Expenses$69.3M
Operating Income-$39.2M
Interest Expense$4.9M
Tax Expense$2.0K
Net Income-$37.4M
EPS (Basic)$-0.25
EPS (Diluted)$-0.25
EBIT-$32.5M
EBITDA-$19.5M
Consolidated Income-$52.5M
Non-Controlling Interests-$15.1M

Balance Sheet

Mar 31, 2026
Cash & Equivalents$243.4M
Accounts Receivable$131.7M
Inventory$57.9M
Current Assets$505.3M
LT Investments$0.00
Property, Plant & Equipment$310.3M
Intangibles$684.0M
Non-Current Assets$1.21B
Total Assets$1.72B
Accounts Payable$91.7M
Current Debt$27.7M
Current Liabilities$415.5M
LT Debt$398.7M
Non-Current Liabilities$571.3M
Total Liabilities$986.8M
Total Debt$426.4M
Retained Earnings-$300.8M
Shareholder Equity-$334.3M
Shares Outstanding216,800,752

Cash Flow Statement

Mar 31, 2026
Operating Cash Flow-$54.8M
Investing Cash Flow-$454.7M
Financing Cash Flow$167.4M
CapEx-$9.9M
Free Cash Flow-$64.6M
Depreciation & Amort.$13.0M
Stock-Based Comp$8.8M
Acquisitions / Disposals-$444.8M
Investment Activity$0.00
Debt Issued/Repaid$0.00
Equity Issued/Repaid$167.5M
Dividends Paid$0.00
Net Change in Cash-$342.0M
Data cached · Meta live · Daily live · Statements live · TTL 24h